Suppr超能文献

CD8+ T 细胞负调节 IL-4 依赖性 IgG1 优势型移植后同种抗体产生。

CD8+ T cells negatively regulate IL-4-dependent, IgG1-dominant posttransplant alloantibody production.

机构信息

Department of Surgery, Comprehensive Transplant Center, Ohio State University Medical Center, Columbus, OH 43210, USA.

出版信息

J Immunol. 2010 Dec 15;185(12):7285-92. doi: 10.4049/jimmunol.1001655. Epub 2010 Nov 17.

Abstract

We have previously reported that CD8(+) T cells significantly influence Ab production based on the observation that posttransplant alloantibody levels in CD8-deficient murine hepatocyte transplant recipients are markedly enhanced. However, the precise mechanisms contributing to enhanced alloantibody production in the absence of CD8(+) T cells is not understood. We hypothesized that alloactivated CD8(+) T cells inhibit Ab production by skewing toward a proinflammatory cytokine profile, whereas when these cells are absent, an anti-inflammatory cytokine profile shifts the alloimmune response toward alloantibody production. To investigate this possibility, alloantibody isotype profiles were examined in CD8-deficient and wild-type hepatocyte recipients. We found that IgG1 (IL-4-dependent isotype) was the dominant alloantibody isotype in wild-type recipients as well as in CD8-deficient recipients, although the amount of alloantibody in the latter group was substantially higher. Utilizing real-time PCR we found that CD4(+) T cells from wild-type recipients significantly upregulated IFN-γ but not IL-4 mRNA. In contrast, in the absence of CD8(+) T cells, CD4(+) T cells switched to significantly upregulate IL-4 mRNA, while IFN-γ was downregulated. IL-4 knockout mice do not produce any posttransplant alloantibody. However, adoptive transfer of wild-type CD4(+) T cells into CD8-depleted IL-4 knockout mice restores high alloantibody levels observed in CD8-depleted wild-type recipients. This suggests that IL-4-producing CD4(+) T cells are critical for posttransplant alloantibody production. Additionally, this CD8-mediated regulation of posttransplant alloantibody production is IFN-γ-dependent. Further elucidation of the mechanisms by which CD8(+) T cells influence Ab production will significantly contribute to development of therapies to manipulate humoral responses to Ag.

摘要

我们之前的研究表明,CD8+ T 细胞显著影响 Ab 产生,其依据是观察到 CD8 缺陷型鼠肝细胞移植受者的移植后同种抗体水平显著增强。然而,CD8+ T 细胞缺失时增强同种抗体产生的确切机制尚不清楚。我们假设,同种激活的 CD8+ T 细胞通过偏向促炎细胞因子谱来抑制 Ab 产生,而当这些细胞缺失时,抗炎细胞因子谱将同种免疫反应转向同种抗体产生。为了研究这种可能性,我们检查了 CD8 缺陷型和野生型肝细胞受者的同种抗体同种型谱。我们发现,IgG1(IL-4 依赖性同种型)是野生型受者以及 CD8 缺陷型受者中主要的同种抗体同种型,尽管后者群体中的同种抗体数量要高得多。利用实时 PCR,我们发现野生型受者的 CD4+ T 细胞显著上调 IFN-γ但不上调 IL-4 mRNA。相反,在缺乏 CD8+ T 细胞的情况下,CD4+ T 细胞转而显著上调 IL-4 mRNA,同时 IFN-γ下调。IL-4 基因敲除小鼠不产生任何移植后同种抗体。然而,将野生型 CD4+ T 细胞过继转移到 CD8 耗竭的 IL-4 基因敲除小鼠中,可恢复在 CD8 耗竭的野生型受者中观察到的高同种抗体水平。这表明产生 IL-4 的 CD4+ T 细胞对于移植后同种抗体产生至关重要。此外,这种 CD8 介导的移植后同种抗体产生的调节是 IFN-γ依赖性的。进一步阐明 CD8+ T 细胞影响 Ab 产生的机制将极大地促进开发用于操纵对 Ag 产生的体液反应的治疗方法。

相似文献

1
CD8+ T cells negatively regulate IL-4-dependent, IgG1-dominant posttransplant alloantibody production.
J Immunol. 2010 Dec 15;185(12):7285-92. doi: 10.4049/jimmunol.1001655. Epub 2010 Nov 17.
4
CD4+ T-cell-dependent immune damage of liver parenchymal cells is mediated by alloantibody.
Transplantation. 2005 Aug 27;80(4):514-21. doi: 10.1097/01.tp.0000168342.57948.68.
5
Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
Transplantation. 2007 Apr 15;83(7):931-7. doi: 10.1097/01.tp.0000257960.07783.e3.
6
Critical role of NKT cells in posttransplant alloantibody production.
Am J Transplant. 2014 Nov;14(11):2491-9. doi: 10.1111/ajt.12922. Epub 2014 Sep 12.
8
Antibody-suppressor CD8+ T Cells Require CXCR5.
Transplantation. 2019 Sep;103(9):1809-1820. doi: 10.1097/TP.0000000000002683.
9
Critical Role of Macrophage FcγR Signaling and Reactive Oxygen Species in Alloantibody-Mediated Hepatocyte Rejection.
J Immunol. 2018 Dec 15;201(12):3731-3740. doi: 10.4049/jimmunol.1800333. Epub 2018 Nov 5.

引用本文的文献

2
Germinal Center B Cells are Uniquely Targeted by Antibody-Suppressor CXCR5CD8 T Cells.
Transplant Direct. 2025 Jan 9;11(2):e1742. doi: 10.1097/TXD.0000000000001742. eCollection 2025 Feb.
4
The longitudinal kinetics of AAV5 vector integration profiles and evaluation of clonal expansion in mice.
Mol Ther Methods Clin Dev. 2024 Jun 26;32(3):101294. doi: 10.1016/j.omtm.2024.101294. eCollection 2024 Sep 12.
5
Recognizing Complexity of CD8 T Cells in Transplantation.
Transplantation. 2024 Nov 1;108(11):2186-2196. doi: 10.1097/TP.0000000000005001. Epub 2024 Apr 19.
7
CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential.
Exp Mol Med. 2023 Nov;55(11):2287-2299. doi: 10.1038/s12276-023-01105-x. Epub 2023 Nov 1.
9
CXCR5CD8 T cells: A Review of their Antibody Regulatory Functions and Clinical Correlations.
J Immunol. 2021 Jun 15;206(12):2775-2783. doi: 10.4049/jimmunol.2100082.
10
Experimental modeling of desensitization: What have we learned about preventing AMR?
Am J Transplant. 2020 Jun;20 Suppl 4(Suppl 4):2-11. doi: 10.1111/ajt.15873.

本文引用的文献

1
IFN-gamma inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response.
J Immunol. 2010 Jul 15;185(2):998-1004. doi: 10.4049/jimmunol.0903372. Epub 2010 Jun 18.
2
Development, regulation and functional capacities of Th17 cells.
Semin Immunopathol. 2010 Mar;32(1):3-16. doi: 10.1007/s00281-009-0187-y. Epub 2010 Jan 27.
3
Interleukin-10: new perspectives on an old cytokine.
Immunol Rev. 2008 Dec;226:205-18. doi: 10.1111/j.1600-065X.2008.00706.x.
5
Murine CD8+ regulatory T lymphocytes: the new era.
Hum Immunol. 2008 Nov;69(11):708-14. doi: 10.1016/j.humimm.2008.08.288. Epub 2008 Sep 24.
7
Human leukocyte antigen antibodies and chronic rejection: from association to causation.
Transplantation. 2008 Aug 15;86(3):377-83. doi: 10.1097/TP.0b013e31817c4cb8.
9
Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10.
Immunity. 2008 Apr;28(4):468-76. doi: 10.1016/j.immuni.2008.03.003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验